Skip to main content
Top
Published in: BMC Ophthalmology 1/2021

Open Access 01-12-2021 | Angiography | Research article

Observation of the characteristics of the natural course of Bietti crystalline dystrophy by fundus fluorescein angiography

Authors: Shengjuan Zhang, Lifei Wang, Zhiqiang Liu, Huijing Sun, Qian Li, Chen Xing, Zhe Xiao, Xiaoyan Peng

Published in: BMC Ophthalmology | Issue 1/2021

Login to get access

Abstract

Background

Bietti crystalline dystrophy (BCD) is an autosomal recessive genetic disorder that causes progressive vision loss. Here, 12 patients were followed up for 1–5 years with fundus fluorescein angiography (FFA) to observe BCD disease progression.

Methods

FFA images were collected for 12 patients with BCD who visited our clinic twice or more over a 5-year period. Peripheral venous blood was collected to identify the pathogenic gene related to the clinical phenotype.

Results

We observed two types in FFA images of patients with BCD. Type 1 showed retinal pigment epithelium (RPE) atrophy in the macular area, followed by choriocapillaris atrophy and the subsequent appearance of RPE atrophy appeared at the peripheral retina. Type 2 showed RPE atrophy at the posterior pole and peripheral retina, followed by choriocapillaris atrophy around the macula and along the superior and inferior vascular arcades and the nasal side of the optic disc. The posterior and peripheral lesions of both type 1 and type 2 BCD subsequently extended to the mid-periphery; finally, all the RPEs and choriocapillaris atrophied, exposing the choroid great vessels, but type 2 macular RPE atrophy could last longer.

Conclusions

The characterization of two different types of BCD development provides a better understanding of the phenotype and the progression of the disease for a precise prognosis and prediction of pathogenesis.
Literature
1.
go back to reference Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet. 2004;74:817–26.CrossRef Li A, Jiao X, Munier FL, Schorderet DF, Yao W, Iwata F, et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am J Hum Genet. 2004;74:817–26.CrossRef
2.
go back to reference Astuti GD, Sun V, Bauwens M, Zobor D, Leroy BP, Omar A, et al. Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti’s retinal dystrophy. Mol Genet Genomic Med. 2015;3:14–29.CrossRef Astuti GD, Sun V, Bauwens M, Zobor D, Leroy BP, Omar A, et al. Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti’s retinal dystrophy. Mol Genet Genomic Med. 2015;3:14–29.CrossRef
3.
go back to reference Bietti GB. Ueber familiares Vorkommen von “Retinitis punctata albescens” (verbunden mit “Dystrophia marginaliscristallinea cornea”): Glitzern des Glaskörpers und anderen degenerativen Augenveränderungen. Klin Monatsbl Augenheilkd. 1937;99:737–56. Bietti GB. Ueber familiares Vorkommen von “Retinitis punctata albescens” (verbunden mit “Dystrophia marginaliscristallinea cornea”): Glitzern des Glaskörpers und anderen degenerativen Augenveränderungen. Klin Monatsbl Augenheilkd. 1937;99:737–56.
4.
go back to reference Bietti GB. Su alcune forme atipiche o rare di degenerazione retinica (degenerazioni tappetoretiniche e quadri morbosi similari). Boll Oculist. 1937;16:1159–244. Bietti GB. Su alcune forme atipiche o rare di degenerazione retinica (degenerazioni tappetoretiniche e quadri morbosi similari). Boll Oculist. 1937;16:1159–244.
5.
go back to reference Mataftsi A, Zografos L, Millá E, Secrétan M, Munier FL. Bietti’s crystalline corneoretinal dystrophy: a cross-sectional study. Retina. 2004;24:416–26.CrossRef Mataftsi A, Zografos L, Millá E, Secrétan M, Munier FL. Bietti’s crystalline corneoretinal dystrophy: a cross-sectional study. Retina. 2004;24:416–26.CrossRef
6.
go back to reference Oishi A, Oishi M, Miyata M, Hirashima T, Hasegawa T, Numa S, et al. Multimodal imaging for differential diagnosis of Bietti crystalline dystrophy. Ophthalmol Retina. 2018;2:1071–7.CrossRef Oishi A, Oishi M, Miyata M, Hirashima T, Hasegawa T, Numa S, et al. Multimodal imaging for differential diagnosis of Bietti crystalline dystrophy. Ophthalmol Retina. 2018;2:1071–7.CrossRef
7.
go back to reference Wang W, Chen W, Bai XY, Chen L. Multimodal imaging features and genetic findings in Bietti crystalline dystrophy. BMC Ophthalmol. 2020;20:331.CrossRef Wang W, Chen W, Bai XY, Chen L. Multimodal imaging features and genetic findings in Bietti crystalline dystrophy. BMC Ophthalmol. 2020;20:331.CrossRef
8.
go back to reference Gocho K, Kameya S, Akeo K, Kikuchi S, Usui A, Yamaki K, et al. High-resolution imaging of patients with Bietti crystalline dystrophy with CYP4V2 mutation. J Ophthalmol. 2014;2014:283603.CrossRef Gocho K, Kameya S, Akeo K, Kikuchi S, Usui A, Yamaki K, et al. High-resolution imaging of patients with Bietti crystalline dystrophy with CYP4V2 mutation. J Ophthalmol. 2014;2014:283603.CrossRef
9.
go back to reference Meng XH, He Y, Zhao TT, Li SY, Liu Y, Yin ZQ. Novel mutations in CYP4V2 in Bietti corneoretinal crystalline dystrophy: Next-generation sequencing technology and genotype-phenotype correlations. Mol Vis. 2019;25:654–62.PubMedPubMedCentral Meng XH, He Y, Zhao TT, Li SY, Liu Y, Yin ZQ. Novel mutations in CYP4V2 in Bietti corneoretinal crystalline dystrophy: Next-generation sequencing technology and genotype-phenotype correlations. Mol Vis. 2019;25:654–62.PubMedPubMedCentral
10.
go back to reference Jiao X, Li A, Jin ZB, Wang X, Iannaccone A, Traboulsi EI, Gorin MB, Simonelli F, Hejtmancik JF. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy. Eur J Hum Genet. 2017;25:461–71.CrossRef Jiao X, Li A, Jin ZB, Wang X, Iannaccone A, Traboulsi EI, Gorin MB, Simonelli F, Hejtmancik JF. Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy. Eur J Hum Genet. 2017;25:461–71.CrossRef
11.
go back to reference Yin X, Yang L, Chen N, Cui H, Zhao L, Feng L, et al. Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystro-phy. Exp Eye Res. 2016;146:154–62.CrossRef Yin X, Yang L, Chen N, Cui H, Zhao L, Feng L, et al. Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystro-phy. Exp Eye Res. 2016;146:154–62.CrossRef
12.
go back to reference Song Y, Mo G, Yin G. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti’s crystalline dystrophy. Int Ophthalmol. 2013;33:269–76.CrossRef Song Y, Mo G, Yin G. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti’s crystalline dystrophy. Int Ophthalmol. 2013;33:269–76.CrossRef
13.
go back to reference Raoof N, Vincent AL. Novel gene mutation in a patient with Bietti crystalline dystrophy without corneal deposits. Clin Exp Ophthalmol. 2017;45:421–4.CrossRef Raoof N, Vincent AL. Novel gene mutation in a patient with Bietti crystalline dystrophy without corneal deposits. Clin Exp Ophthalmol. 2017;45:421–4.CrossRef
14.
go back to reference Toto L, Carpineto P, Parodi MB, Di Antonio L, Mastropasqua A, Mastropasqua L. Spectral domain optical coherence tomography and in vivo confocal microscopy imaging of a case of Bietti’s crystalline dystrophy. Clin Exp Optom. 2013;96:39–45.CrossRef Toto L, Carpineto P, Parodi MB, Di Antonio L, Mastropasqua A, Mastropasqua L. Spectral domain optical coherence tomography and in vivo confocal microscopy imaging of a case of Bietti’s crystalline dystrophy. Clin Exp Optom. 2013;96:39–45.CrossRef
15.
go back to reference Yokoi Y, Sato K, Aoyagi H, Takahashi Y, Yamagami M. NakazawaM. A novel compound heterozygous mutation in the CYP4V2 gene in a japanese patient with Bietti’s crystalline corneoretinal dystrophy. Case Rep Ophthalmol. 2011;2:296–301.CrossRef Yokoi Y, Sato K, Aoyagi H, Takahashi Y, Yamagami M. NakazawaM. A novel compound heterozygous mutation in the CYP4V2 gene in a japanese patient with Bietti’s crystalline corneoretinal dystrophy. Case Rep Ophthalmol. 2011;2:296–301.CrossRef
16.
go back to reference Mansour AM, Uwaydat SH, Chan CC. Long-term follow-up in Bietti crystalline dystrophy. Eur J Ophthalmol. 2007;17:680–2.CrossRef Mansour AM, Uwaydat SH, Chan CC. Long-term follow-up in Bietti crystalline dystrophy. Eur J Ophthalmol. 2007;17:680–2.CrossRef
17.
go back to reference Lockhart CM, Smith TB, Yang P, Naidu M, Rettie AE, Nath A, et al. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2. Br J Ophthalmol. 2018;102:187–94.CrossRef Lockhart CM, Smith TB, Yang P, Naidu M, Rettie AE, Nath A, et al. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2. Br J Ophthalmol. 2018;102:187–94.CrossRef
18.
go back to reference Ipek SC, Ayhan Z, Kadayifcilar S, Saatci AO. Swept-source optical coherence tomography angiography in a patient with Bietti crystalline dystrophy followed for ten years. Turk J Ophthalmol. 2019;49:106–8.CrossRef Ipek SC, Ayhan Z, Kadayifcilar S, Saatci AO. Swept-source optical coherence tomography angiography in a patient with Bietti crystalline dystrophy followed for ten years. Turk J Ophthalmol. 2019;49:106–8.CrossRef
19.
go back to reference Lee KY, Koh AH, Aung T, Yong VH, Yeung K, Ang CL, Vithana EN. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci. 2005;46:3812–6.CrossRef Lee KY, Koh AH, Aung T, Yong VH, Yeung K, Ang CL, Vithana EN. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci. 2005;46:3812–6.CrossRef
20.
go back to reference Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388–91.CrossRef Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388–91.CrossRef
21.
go back to reference Yuzawa M, Mae Y, Matsui M. Bietti’s crystalline dystrophy. Ophthalmic Paediatr Genet. 1986;7:9–20.CrossRef Yuzawa M, Mae Y, Matsui M. Bietti’s crystalline dystrophy. Ophthalmic Paediatr Genet. 1986;7:9–20.CrossRef
22.
go back to reference Li Q, Li Y, Zang X, Xu Z, Zhu X, Ma K, et al. Utilization of fundus autofluorescence, spectral domain optical coherence tomography, and enhanced depth imaging in the characterization of Bietti crystalline dystrophy in different stages. Retina. 2015;35:2074–84.CrossRef Li Q, Li Y, Zang X, Xu Z, Zhu X, Ma K, et al. Utilization of fundus autofluorescence, spectral domain optical coherence tomography, and enhanced depth imaging in the characterization of Bietti crystalline dystrophy in different stages. Retina. 2015;35:2074–84.CrossRef
23.
go back to reference Fong AM, Koh A, Lee K, Ang CL. Bietti’s crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics. Int Ophthalmol. 2009;29:459–70.CrossRef Fong AM, Koh A, Lee K, Ang CL. Bietti’s crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics. Int Ophthalmol. 2009;29:459–70.CrossRef
24.
go back to reference Rossi S, Testa F, Li A, Iorio VD, Zhang J, Gesualdo C, et al. An atypical form of Bietti crystalline dystrophy. Ophthalmic Genet. 2011;32:118–21.CrossRef Rossi S, Testa F, Li A, Iorio VD, Zhang J, Gesualdo C, et al. An atypical form of Bietti crystalline dystrophy. Ophthalmic Genet. 2011;32:118–21.CrossRef
25.
go back to reference Miyata M, Oishi A, Hasegawa T, Ishihara K, Oishi M, Ogino K, et al. Choriocapillaris flow deficit in Bietti crystalline dystrophy detected using optical coherence tomography angiography. Br J Ophthalmol. 2018;102:1208–12.CrossRef Miyata M, Oishi A, Hasegawa T, Ishihara K, Oishi M, Ogino K, et al. Choriocapillaris flow deficit in Bietti crystalline dystrophy detected using optical coherence tomography angiography. Br J Ophthalmol. 2018;102:1208–12.CrossRef
26.
go back to reference Halford S, Liew G, Mackay DS, Sergouniotis PI, Holt R, Broadgate S, et al. Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy. Ophthalmology. 2014;121:1174–84.CrossRef Halford S, Liew G, Mackay DS, Sergouniotis PI, Holt R, Broadgate S, et al. Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy. Ophthalmology. 2014;121:1174–84.CrossRef
27.
go back to reference Chen H, Zhang M, Huang S, Wu D. Functional and clinical findings in 3 female siblings with crystalline retinopathy. Doc Ophthalmol. 2008;116:237–43.CrossRef Chen H, Zhang M, Huang S, Wu D. Functional and clinical findings in 3 female siblings with crystalline retinopathy. Doc Ophthalmol. 2008;116:237–43.CrossRef
28.
go back to reference Liu DN, Liu Y, Meng XH, Yin ZQ. The characterization of functional disturbances in Chinese patients with Bietti’s crystalline dystrophy at different fundus stages. Graefes Arch Clin Exp Ophthalmol. 2012;250:191–200.CrossRef Liu DN, Liu Y, Meng XH, Yin ZQ. The characterization of functional disturbances in Chinese patients with Bietti’s crystalline dystrophy at different fundus stages. Graefes Arch Clin Exp Ophthalmol. 2012;250:191–200.CrossRef
29.
go back to reference Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE. CYP4V2 in Bietti’s crystalline dystrophy: ocular localization, metabolism of omega-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol Pharmacol. 2012;82:679–86.CrossRef Nakano M, Kelly EJ, Wiek C, Hanenberg H, Rettie AE. CYP4V2 in Bietti’s crystalline dystrophy: ocular localization, metabolism of omega-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol Pharmacol. 2012;82:679–86.CrossRef
30.
go back to reference Rossi S, Testa F, Li A, Yaylacioglu F, Gesualdo C, Hejtmancik JF, Simonelli F. Clinical and genetic features in Italian Bietti crystalline dystrophy patients. Br J Ophthalmol. 2013;97:174–9.CrossRef Rossi S, Testa F, Li A, Yaylacioglu F, Gesualdo C, Hejtmancik JF, Simonelli F. Clinical and genetic features in Italian Bietti crystalline dystrophy patients. Br J Ophthalmol. 2013;97:174–9.CrossRef
31.
go back to reference Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA. 2009;106:18751–6.CrossRef Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA. 2009;106:18751–6.CrossRef
32.
go back to reference Jin ZB, Ito S, Saito Y, Inoue Y, Yanagi Y. Nao-i N. Clinical and molecular findings in three Japanese patients with crystalline retinopathy. Jpn J Ophthalmol. 2006;50:426–31.CrossRef Jin ZB, Ito S, Saito Y, Inoue Y, Yanagi Y. Nao-i N. Clinical and molecular findings in three Japanese patients with crystalline retinopathy. Jpn J Ophthalmol. 2006;50:426–31.CrossRef
33.
go back to reference Broadhead GK, Chang AA. Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy. Korean J Ophthalmol. 2014;28:89–191.CrossRef Broadhead GK, Chang AA. Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy. Korean J Ophthalmol. 2014;28:89–191.CrossRef
Metadata
Title
Observation of the characteristics of the natural course of Bietti crystalline dystrophy by fundus fluorescein angiography
Authors
Shengjuan Zhang
Lifei Wang
Zhiqiang Liu
Huijing Sun
Qian Li
Chen Xing
Zhe Xiao
Xiaoyan Peng
Publication date
01-12-2021
Publisher
BioMed Central
Keyword
Angiography
Published in
BMC Ophthalmology / Issue 1/2021
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-021-01999-z

Other articles of this Issue 1/2021

BMC Ophthalmology 1/2021 Go to the issue